Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B

Journal of Drug Targeting

Volumn 19, Issue 1, 2011, Pages 67-78

  Mishra, Neeraj ^a   Tiwari, Shailja ^a   Vaidya, Bhuvaneshwar ^a   Agrawal, Govind P ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Hepatitis B; lectin; M cells; mucosal immunization; nanoparticles

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 2; LECTIN; NANOCARRIER; NANOPARTICLE; POLYGLACTIN; SECRETORY IMMUNOGLOBULIN;

ARTICLE; ASPARAGUS; ASPARAGUS PEA; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENCAPSULATION; HEPATITIS B; IMMUNIZATION; IMMUNOSTIMULATION; INTESTINE; LOTUS; LOTUS TETRAGONOLOBUS; MOUSE; MOUTH MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SALIVA; TISSUE HOMOGENATE; VAGINA SECRETION; ZETA POTENTIAL;

ANIMALS; CATTLE; DRUG DELIVERY SYSTEMS; FEMALE; FUCOSE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; LACTIC ACID; LOTUS; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MUCINS; NANOPARTICLES; PLANT LECTINS; POLYGLYCOLIC ACID;

EID: 78650042168     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611861003733946     Document Type: Article

References (59)

1. Aramaki Y, Tomizawa H, Hara T, Yachi K, Kikuchi H, Tsuchiya S. (1993). Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration. Pharm Res, 10, 1228-1231.
2. Chu BC, Kramer FR, Orgel LE. (1986). Synthesis of an amplifiable reporter RNA for bioassays. Nucleic Acids Res, 14, 5591-5603.
3. Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH. (1993). Differential expression of lectin-binding sites defines mouse intestinal M-cells. J Histochem Cytochem, 41, 1679-1687.
4. Cleland JL, Jones AJ. (1996). Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm Res, 13, 1464-1475.
5. Coombes AGA, Yeh MK, Lavelle EC, Davis SS. (1998). The control of protein release from poly (DL-lactide-co-glycolide) microparticles by variation of external aqueous phase surfactant in the water in oil in water method. J Control Rel, 52, 311-320.
6. des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release, 116, 1-27.
7. De Souza JB, Ling IT, Ogun SA, Holder AA, Playfair JH. (1996). Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant. Infect Immun, 64, 3532-3536.
8. Elson CO, Ealding W, Lefkowitz J. (1984). A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods, 67, 101-108.
9. Ertl B, Heigl F, Wirth M, Gabor F. (2000). Lectin-mediated bioadhesion: Preparation, stability and caco-2 binding of wheat germ agglutinin- functionalized Poly(D,L-lactic-co-glycolic acid)-microspheres. J Drug Target, 8, 173-184.
10. Ezpeleta I, Irache JM, Stainmesee S, Chabenat C, Gueguen J, and Orecchioni AM. (1996). Peparation of lectin - vicilin nanoparticle conjugates using the carbodiimide coupling technique. Int J Pharm, 142, 227-233.
11. Fievez V, Plapied L, des Rieux A, Pourcelle V, Freichels H, Wascotte V, Vanderhaeghen ML, Jerôme C, Vanderplasschen A, Marchand- Brynaert J, Schneider YJ, Préat V. (2009). Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur J Pharm Biopharm, 73, 16-24.
12. Foster N, Clark MA, Jepson MA, Hirst BH. (1998). Ulex europaeus 1 lectin targets microsphers to mouse Peyer's patch M cells in vivo. Vaccine, 16, 536-541.
13. Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X, Fu S. (2006). Lectinconjugated PEG-PLA nanoparticles: Preparation and brain delivery after intranasal administration. Biomaterials, 27, 3482-3490.
14. Gabor F, Bogner E, Weissenboeck A, Wirth M. (2004). The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliv Rev, 56, 459-480.
15. Gabor F, Stangl M, Wirth M. (1998). Lectin-mediated bioadhesion: Binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. J Control Release, 55, 131-142.
16. Gabor F, Schwarzbauer A, Wirth M. (2002). Lectin-mediated drug delivery: Binding and uptake of BSA-WGA conjugates using the Caco-2 model. Int J Pharm, 237, 227-239.
17. Ghosh SS, Kao PM, McCue AW, Chappelle HL. (1990). Use of maleimide- thiol coupling chemistry for efficient syntheses of oligonucleotide- enzyme conjugate hybridization probes. Bioconjug Chem, 1, 71-76.
18. Gebert A, Rothkötter HJ, Pabst R. (1996). M cells in Peyer's patches of the intestine. Int Rev Cytol, 167, 91-159.
19. Grabarek Z, Gergely J. (1990). Zero-length crosslinking procedure with the use of active esters. Anal Biochem, 185, 131-135.
20. Gref R, Domb A, Quellec P, Blunk T, Muller RH, Verbavats JM, Langer R. (1995). The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev, 16, 215-223.
21. Gupta PN, Khatri K, Goyal AK, Mishra N, Vyas SP. (2007). M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target, 15, 701-713.
22. Gupta PN, Mahor S, Rawat A, Khatri K, Goyal A, Vyas SP. (2006). Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation. Int J Pharm, 318, 163-173.
23. Honda S, Suzuki S. (1984). Common conditions for high-performance liquid chromatographic microdetermination of aldoses, hexosamines, and sialic acids in glycoproteins. Anal Biochem, 142, 167-174.
24. Jaganathan KS, Vyas SP. (2006). Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine, 24, 4201-4211.
25. Jaganathan KS, Singh P, Prabakaran D, Mishra V, Vyas SP. (2004). Development of a single-dose stabilized poly(D,L-lactic-coglycolic acid) microspheres-based vaccine against hepatitis B. J Pharm Pharmacol, 56, 1243-1250.
26. Jain S, Singh P, Mishra V, Vyas SP. (2005). Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett, 101, 41-49.
27. Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP. (2008). Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine, 26, 2225-2233.
28. Kilpatrick DC, Pusztai A, Grant G, Graham C, Ewen SW. (1985). Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects. FEBS Lett, 185, 299-305.
29. Lavelle EC, Grant G, Pusztai A, Pfüller U, O'Hagan DT. (2001). The identification of plant lectins with mucosal adjuvant activity. Immunology, 102, 77-86.
30. Lavelle EC, Grant G, Pfuller U, O'Hagan DT. (2004). Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. J Drug Target, 12, 89-95.
31. Lee VHL, Yamamoto A. (1989). Penetration and enzymatic barriers to peptide and protein absorption. Adv Drug Deliv Rev, 4, 171-207.
32. Lehr CM, Bouwstra JA, Kok W, Noach AB, de Boer AG, Junginger HE. (1992). Bioadhesion by means of specific binding of tomato lectin. Pharm Res, 9, 547-553.
33. Lis H, Sharon N. (1986). Lectins as molecules and as tools. Annu Rev Biochem, 55, 35-67.
34. Montisci MJ, Giovannuci G, Duchêne D, Ponchel G. (2001a). Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres. Int J Pharm, 215, 153-161.
35. Montisci MJ, Dembri A, Giovannuci G, Chacun H, Duchêne D, Ponchel G. (2001b). Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats. Pharm Res, 18, 829-837.
36. Nakane A, Numata A, Minagawa T. (1992). Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect Immun, 60, 523-528.
37. Neutra MR, Sansonetti PJ, Kraehenbuhl JP. (2003). M Cells and Microbial Pathogens. Raven Press Berlin, 163-178.
38. O'Hagan DT. (1998). Microparticles and polymers for the mucosal delivery of vaccines. Adv Drug Del Rev, 34, 305-320.
39. Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Ithakissios DS, Avgoustakis K. (2001). Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm, 221, 143-152.
40. Pereira ME, Kabat EA. (1974). Specificity of purified hemagglutinin (lectin) from Lotus tetragonolobus. Biochemistry, 13, 3184-3192.
41. Perrie Y, Gregoriadis G. (2000). Liposome-entrapped plasmid DNA: Characterisation studies. Biochim Biophys Acta, 1475, 125-132.
42. Ponchel G, Irache J. (1998). Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev, 34, 191-219.
43. Russell-Jones GJ, Veitch H, Arthur L. (1999). Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int J Pharm, 190, 165-174.
44. Roth-Walter F, Schöll I, Untersmayr E, Ellinger A, Boltz-Nitulescu G, Scheiner O, Gabor F, Jensen-Jarolim E. (2005). Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin. Vaccine, 23, 2703-2710.
45. Roth-Walter F, Schöll I, Untersmayr E, Fuchs R, Boltz-Nitulescu G, Weissenböck A, Scheiner O, Gabor F, Jensen-Jarolim E. (2004). M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy. J Allergy Clin Immunol, 114, 1362-1368.
46. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. (2002). Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 82, 105-114.
47. Shenderova A, Burke TG, Schwendeman SP. (1999). The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm Res, 16, 241-248.
48. Shi L, Caulfield MJ, Chern RT, Wilson RA, Sanyal G, Volkin DB. (2002). Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci, 91, 1019-1035.
49. Shukla A, Khatri K, Gupta PN, Goyal AK, Mehta A, Vyas SP. (2008). Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci, 11, 59-66.
50. Singh M, Li XM, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT. (1997). Controlled release microparticles as a single dose hepatitis B vaccine: Evaluation of immunogenicity in mice. Vaccine, 15, 475-481.
51. Singh P, Prabakaran D, Jain S, Mishra V, Jaganathan KS, Vyas SP. (2004). Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm, 278, 379-390.
52. Staros JV, Wright RW, Swingle DM. (1986). Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem, 156, 220-222.
53. Tobío M, Gref R, Sánchez A, Langer R, Alonso MJ. (1998). Stealth PLAPEG nanoparticles as protein carriers for nasal administration. Pharm Res, 15, 270-275.
54. Venkatesan N, Vyas SP. (2000). Polysaccharide coated liposomes for oral immunization-development and characterization. Int J Pharm, 203, 169-177.
55. Vyas SP, Sihorkar V, Dubey PK. (2001). Preparation, characterization and in-vitro antimicrobial activity of metronidazole bearing lectinized liposomes for intra peridontal pocket delivery. Pharmazie, 56, 554-560.
56. Walter F, Schöll I, Untersmayr E, Ellinger A, Boltz-Nitulescu G, Scheiner O, Gabor F, Jensen-Jarolim E. (2004). Functionalisation of allergen-loaded microspheres with wheat germ agglutinin for targeting enterocytes. Biochem Biophys Res Commun, 315, 281-287.
57. Wang S, Liu X, Caulfield MJ. (2003). Adjuvant synergy in the response to hepatitis B vaccines. Vaccine, 21, 4297-4306.
58. Weissenböck A, Wirth M, Gabor F. (2004). WGA-grafted PLGAnanospheres: Preparation and association with Caco-2 single cells. J Control Release, 99, 383-392.
59. Zhu G, Mallery SR, Schwendeman SP. (2000). Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide). Nat Biotechnol, 18, 52-57.